Young-Yul Kim | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Prof. Dr. Young-Yul Kim | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Department Of Orthopedics | Catholic University of Korea | South Korea

Prof. Dr. Young-Yul Kim is a highly cited researcher in orthopedic spine surgery and regenerative biomaterials, with 2,505 Google Scholar citations across 111 scholarly documents, reflecting a strong h-index of 24 and i10-index of 52. His research integrates clinical spine science with advanced biomaterials, focusing on intervertebral disc degeneration, spinal disorders, biodegradable magnesium alloys, polymer-based and 3D/4D-printed scaffolds, and bone and cartilage regeneration. He has authored influential journal articles, high-impact reviews, and translational studies published in leading international journals, with several works serving as key references in disc biology, autophagy, necroptosis, and scaffold-based tissue engineering. His contributions extend to funded multidisciplinary research projects, innovation-driven R&D, and patented concepts in biodegradable implants and regenerative platforms. Prof. Dr. Young-Yul Kim has received multiple research awards and recognitions, actively contributes as a reviewer and editorial participant for international journals, and plays a significant role in shaping scientific discourse through conference leadership and invited scholarly activities, demonstrating sustained global research impact and innovation leadership.

Citation Metrics (Google Scholar)

3000

2500

2000

1500

1000

500

0

Citations
2505

Documents
111

h-index
24

i10index
52

Citations

Documents

h-index

i10-index

View Scopus Profile  View ORCID Profile  View Google Scholar  View ResearchGate  View Sci Profiles  View Researcher Profile

Featured Publications

Arthroscopic fixation technique for comminuted, displaced greater tuberosity fracture
Arthroscopy: The Journal of Arthroscopic & Related Surgery, 2010 | Citations: 126

Vibha Joshi | Nanotechnology in Medicine and Healthcare | Best Researcher Award

Dr. Vibha Joshi | Nanotechnology in Medicine and Healthcare | Best Researcher Award

Teaching Associate | DIT University (Dehradun Institute of Technology) | India

Dr. Vibha Joshi is an emerging researcher with 216 citations, 23 scholarly documents, an h-index of 9, and an i10-index of 9, reflecting strong and growing research impact. Her research focuses on green and sustainable nanotechnology, nanomaterials for biomedical and environmental applications, phytochemistry, catalysis, corrosion inhibition, and targeted drug delivery systems. She has made notable contributions to the green synthesis of metal and metal-oxide nanoparticles, carbon dots, quantum dots, and nanocomposites, integrating in vitro, in vivo, and in silico approaches. Her work addresses critical challenges in antidiabetic, antioxidant, antibacterial, anticancer, and anticorrosion applications, with publications in high-impact Q1 and Q2 international journals. Dr. Vibha Joshi is a patent holder in nanoformulations and functional nanomaterials and has contributed to book chapters on advanced nanostructured materials and herbal nanomedicine. She actively serves as a peer reviewer for reputed journals and contributes to interdisciplinary research advancing sustainable nanoscience, medicinal chemistry, and applied materials research.

Citation Metrics (Google Scholar)

250

200

150

100

50

0

Citations
216

Documents
24

h-index
9

i10index
9

Citations

Documents

h-index

i10-index

View Scopus Profile   View ORCID Profile   View Google Scholar   View ResearchGate

Featured Publications

Héctor Javier Sánchez | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Dr. Héctor Javier Sánchez | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Subject Professor | Technological University of Coahuila | Mexico

Dr. Héctor Javier Sánchez is an active materials science researcher whose work centers on the synthesis, characterization, and biomedical integration of magnetic nanomaterials. His contributions span more than a decade and encompass extensive research on ferrite-based nanoparticles engineered for hyperthermia therapy, diagnostic imaging, toxin adsorption, and multifunctional biomedical applications. His publication record includes numerous peer-reviewed articles in high-impact journals such as Ceramics International, Journal of Magnetism and Magnetic Materials, Journal of Materials Science: Materials in Medicine, Colloids and Surfaces A, and Journal of Alloys and Compounds. These works highlight advances in sol-gel synthesis, thermal decomposition, nanoparticle coating strategies, and the evaluation of structural, magnetic, heating, biocompatibility, and hemolysis properties of materials across systems such as Fe-Ga, Mn-Ga, Co-Ga, Mg-Mn, Mg-Zn, Ti-doped ferrites, and Zn-Mg ferrites. Dr. Héctor Javier Sánchez has also contributed to technological development projects focused on magnetic nanoparticle platforms for cancer hyperthermia, supported by innovation and government funding programs. His participation includes producing final technical reports and advancing R&D packages involving Fe-Ga-Co systems and biomedical coating methodologies for enhanced stability and therapeutic performance. His research dissemination extends to numerous international and national conferences, where he has presented over 30 contributions covering nanoparticle synthesis routes, crystallographic behavior, magnetic induction performance, cytotoxicity studies, and polymer–nanoparticle composites for advanced functional applications. He has also co-authored a book chapter published by the American Ceramics Society, addressing next-generation bioceramics and magnetic materials processing. Dr. Héctor Javier Sánchez’s work reflects a strong focus on innovation in nanomagnetism, bioceramics, and advanced materials engineering. With over 312 citations, 15 documents, and an h-index of 10 (Scopus), multiple collaborative projects, and recognized contributions to magnetic hyperthermia research, he continues to advance the frontier of nanotechnology-enabled biomedical solutions.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Reyes-Rodríguez, P. Y., Cortés-Hernández, D. A., Escobedo-Bocardo, J. C., Almanza-Robles, J. M., Sánchez-Fuentes, H. J., Jasso-Terán, A., De León-Prado, L. E., Méndez-Nonell, J., & Hurtado-López, G. F. (2017). Structural and magnetic properties of Mg–Zn ferrites (Mg₁₋ₓZnₓFe₂O₄) prepared by sol–gel method. Journal of Magnetism and Magnetic Materials, 427, 268–271. https://doi.org/10.1016/j.jmmm.2016.10.078

2. Jasso-Terán, R. A., Cortés-Hernández, D. A., Sánchez-Fuentes, H. J., Reyes-Rodríguez, P. Y., de-León-Prado, L. E., Escobedo-Bocardo, J. C., & Almanza-Robles, J. M. (2017). Synthesis, characterization and hemolysis studies of Zn₍₁₋ₓ₎CaₓFe₂O₄ ferrites synthesized by sol–gel for hyperthermia treatment applications. Journal of Magnetism and Magnetic Materials, 427, 241–244. https://doi.org/10.1016/j.jmmm.2016.10.099

3. Sánchez, J., Cortés-Hernández, D. A., Escobedo-Bocardo, J. C., Jasso-Terán, R. A., & Zugasti-Cruz, A. (2014). Bioactive magnetic nanoparticles of Fe–Ga synthesized by sol–gel for their potential use in hyperthermia treatment. Journal of Materials Science: Materials in Medicine, 25(10), 2237–2242. https://doi.org/10.1007/s10856-014-5197-1

4. De-León-Prado, L. E., Cortés-Hernández, D. A., Almanza-Robles, J. M., Escobedo-Bocardo, J. C., Sánchez, J., Reyes-Rodríguez, P. Y., Jasso-Terán, R. A., & Hurtado-López, G. F. (2017). Synthesis and characterization of nanosized MgₓMn₁₋ₓFe₂O₄ ferrites by both sol–gel and thermal decomposition methods. Journal of Magnetism and Magnetic Materials, 427, 230–234. https://doi.org/10.1016/j.jmmm.2016.11.036

5. Sánchez, J., Rodríguez-Reyes, M., Cortés-Hernández, D. A., Ávila-Orta, C. A., & Reyes-Rodríguez, P. Y. (2021). Heating capacity and biocompatibility of Pluronic-coated manganese gallium ferrites for magnetic hyperthermia treatment. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 612, 125986. https://doi.org/10.1016/j.colsurfa.2020.125986

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Ms. Moloud Farrokhi , Albany Medical college, United States

Mouloud Farrokhi is an experienced immunologist and microbiologist specializing in HIV/AIDS research, nanoparticle delivery systems, and viral infections. He is currently pursuing a PhD in Biology with a focus on Immunology and Microbiology at Albany Medical College, USA. Mouloud has a strong academic and professional background, having worked as a research assistant and medical laboratory scientist in Iran and Sweden. His research aims to improve understanding and treatment of viral infections, with significant contributions to HIV drug resistance and oncolytic virus therapy. Mouloud’s work also extends to the development of innovative nanoparticle-based drug delivery systems, offering promising solutions for invasive infections like Aspergillosis. His expertise spans from molecular biology to clinical research, with an emphasis on laboratory techniques like PCR, qRT-PCR, NGS, and CRISPR/Cas9.

Professional Profile:

Google Scholar

Mouloud Farrokhi: A Strong Contender for the Research Best Researcher Award

Mouloud Farrokhi is an exceptional candidate for the Research Best Researcher Award due to his extensive background in immunology, microbiology, and viral infections, as well as his significant contributions to molecular diagnostics and therapeutic innovations. His educational qualifications, research experience, and recognition in the field of medical sciences make him a highly suitable candidate for this prestigious award.

🎓Education:

Mouloud Farrokhi is currently pursuing a PhD in Biology, specializing in Immunology and Microbiology at Albany Medical College, USA (2023–Present). He holds two Master’s degrees: an MSc in Bioscience from the University of Skövde, Sweden (2021–2022), with a thesis on the role of RABL6 in AP3-dependent trafficking, and an MSc in Cellular and Molecular Biology from the Islamic Azad University, Iran (2010–2014), where he researched HIV-1 drug resistance. His undergraduate studies were in Marine Biology at the Islamic Azad University, Tehran, Iran (2003–2008). Mouloud’s extensive education in biological sciences provides a solid foundation for his current research endeavors, focusing on viral infections, molecular diagnostics, and therapeutic innovations.

🏢Experience:

Mouloud Farrokhi has gained extensive experience as a research assistant and medical laboratory scientist. He worked as a Research Assistant at Tehran University of Medical Sciences (2022–2023), where he focused on statistical analysis and NGS (Next Generation Sequencing). He has also served as a Medical Laboratory Assistant at Tehran University of Medical Sciences (2018–2021), where he conducted HIV viral load analysis and COVID-19 testing via qPCR. His previous roles include being a Medical Laboratory Scientist at Dena Lab (2017–2018), where he performed NITP tests and a Research Assistant at Pasteur Institute of Iran (2016–2017), where he researched drug resistance in HIV and HCV. He has also contributed to laboratory work at Keyvan Virology Laboratory, Tehran (2015–2016). Mouloud’s diverse hands-on experience makes him proficient in molecular biology techniques, data analysis, and lab management.

🏅Awards and Honors:

Mouloud Farrokhi’s academic and research achievements are reflected in his high academic standing and contributions to scientific research. His thesis at the University of Skövde received top marks, with a GPA of 3.75, and he has consistently demonstrated excellence throughout his academic career. His research contributions have been recognized in various publications and presentations. Notably, he presented at the International Student Congress in Medical Sciences (ISCOM) in 2017 and at the Upstate New York Immunology Conference (NYIC) in 2024. Mouloud’s work in HIV drug resistance and nanoparticle drug delivery systems has been published in high-impact journals. His dedication to advancing medical science has led to multiple research opportunities, including participation in workshops on gene transfer and vaccine design.

🔬Research Focus:

Mouloud Farrokhi’s research focuses on immunology, microbiology, and the molecular mechanisms underlying viral infections and drug resistance. He investigates the molecular pathways of HIV and other viral infections, focusing on drug resistance mechanisms in HIV-1 and HCV. His research also explores innovative strategies for oncolytic virus therapy and nanoparticle-based drug delivery, with the goal of improving treatment outcomes for invasive infections like Aspergillosis. Additionally, he is involved in genetic analysis and genomic editing technologies such as CRISPR/Cas9. Mouloud’s work integrates molecular diagnostics and therapeutic advancements, contributing significantly to both basic science and clinical applications in virology and immunology.

Publication Top Notes:

  • “Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013”
    • Citations: 31
  • “HIV drug resistance among naïve HIV-infected patients in Iran”
    • Citations: 14
  • “Antiretroviral drug resistance mutations among HIV treatment failure patients in Tehran, Iran”
    • Citations: 11
  • “The first characterization of HIV-1 subtypes and drug resistance mutations among antiretrovirally treated patients in Kermanshah, Iran”
    • Citations: 9
  • “HIV drug resistance and phylogeny profile in naive and antiretroviral-experienced patients in Tehran, Iran”
    • Citations: 8